CNTX Context Therapeutics Inc.

Fundamentals / CIK 0001842952 / USD

Context Therapeutics Inc. reported $36.54M in total assets and a net loss of $43.89M through December 31, 2025 from SEC EDGAR filings.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CNTX in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$10.36M$5.18M$0-$34.34MFY 2020 Net Income: $6.64M2020FY 2021 Net Income: -$10.46M2021FY 2022 Net Income: -$14.84M2022FY 2023 Net Income: -$23.96M2023FY 2024 Net Income: -$26.73M2024FY 2025 Net Income: -$36.12M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Research & Development $31.86M $22.70M $17.78M $7.09M $3.81M $1.64M
Operating Income -$39.70M -$29.92M -$25.07M -$15.38M -$10.53M -$2.57M
EBITDA -$39.69M -$29.91M -$25.06M -$15.37M -$10.53M --
Interest Income $3.38M $3.20M $1.16M -- -- --
Interest Expense -- -- -- -- $64K $661K
Income Tax Expense $0 $0 $0 $0 $0 $0
Net Income -$36.12M -$26.73M -$23.96M -$14.84M -$10.46M $6.64M
Basic EPS -$0.38 -$0.46 -$1.50 -$0.93 -$3.69 $3.07
Diluted EPS -$0.38 -$0.46 -$1.50 -$0.93 -$3.69 -$3.96
Basic Shares Outstanding 95.2M 58.4M 16.0M 16.0M 2.8M 348.4K
Diluted Shares Outstanding 95.2M 58.4M 16.0M 16.0M 2.8M 2.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Research & Development $5.72M $12.53M $7.02M $11.84M $8.72M $7.83M $3.46M $2.52M
Operating Income -$7.96M -$14.97M -$9.34M -$13.80M -$10.61M -$9.76M -$5.53M -$4.31M
EBITDA -$7.95M -$14.96M -$9.34M -$13.80M -$10.61M -$9.75M -$5.53M -$4.31M
Interest Income $332K $419K $520K $682K $834K $904K $959K $964K
Net Income -$7.62M -$14.56M -$8.68M -$13.03M -$9.69M -$8.83M -$4.58M -$3.34M
Basic EPS -$0.08 -$0.15 -$0.09 -- -$0.10 -$0.09 -$0.05 --
Diluted EPS -$0.08 -$0.15 -$0.09 -- -$0.10 -$0.09 -$0.05 --
Basic Shares Outstanding 95.2M 95.2M 95.2M -- 95.2M 95.2M 95.2M --
Diluted Shares Outstanding 95.2M 95.2M 95.2M -- 95.2M 95.2M 95.2M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $66.00M $94.43M $14.45M $35.50M $49.64M $291K
Cash & Short-Term Investments $66.00M $94.43M $14.45M $35.50M $49.64M $291K
Total Current Assets $68.35M $97.90M $16.05M $37.85M $51.26M $299K
Property, Plant & Equipment, Net $30K $12K $16K $28K $0 --
Other Non-Current Assets -- -- $0 $33K $0 --
Total Non-Current Assets $140K $231K $16K $112K $50K $168K
Total Assets $68.49M $98.13M $16.06M $37.97M $51.31M $467K
Accounts Payable $2.53M $1.45M $2.38M $936K $1.83M $2.71M
Total Current Liabilities $8.02M $2.75M $4.19M $3.21M $3.03M $9.55M
Total Non-Current Liabilities $0 $112K $0 $0 $0 $69K
Total Liabilities $8.02M $2.86M $4.19M $3.21M $3.03M $9.62M
Total Debt (incl. Leases) $100K $200K -- $55K -- --
Common Stock $92K $90K $16K $16K $16K $332
Retained Earnings -$130.9M -$94.78M -$68.05M -$44.09M -$29.25M -$18.80M
Total Stockholders' Equity $60.47M $95.27M $11.87M $34.76M $48.27M -$16.92M
Total Equity $60.47M $95.27M $11.87M $34.76M $48.27M -$16.92M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $34.41M $42.99M $54.53M $66.00M $76.94M $83.52M $89.35M $94.43M
Cash & Short-Term Investments $34.41M $42.99M $54.53M $66.00M $76.94M $83.52M $89.35M $94.43M
Total Current Assets $36.27M $45.82M $58.52M $68.35M $79.06M $86.95M $92.73M $97.90M
Property, Plant & Equipment, Net $67K $74K $62K $30K $34K $38K $42K $12K
Total Non-Current Assets $268K $315K $342K $140K $172K $204K $235K $231K
Total Assets $36.54M $46.13M $58.86M $68.49M $79.23M $87.15M $92.97M $98.13M
Accounts Payable $1.60M $3.29M $2.47M $2.53M $2.72M $2.40M $1.00M $1.45M
Total Current Liabilities $5.50M $7.88M $6.53M $8.02M $6.04M $4.56M $1.90M $2.75M
Total Non-Current Liabilities $31K $78K $122K $0 $21K $52K $83K $112K
Total Liabilities $5.53M $7.96M $6.66M $8.02M $6.06M $4.61M $1.98M $2.86M
Total Debt (incl. Leases) $200K $200K $300K $100K $100K $200K $200K $200K
Common Stock $92K $92K $92K $92K $92K $90K $90K $90K
Retained Earnings -$161.8M -$154.1M -$139.6M -$130.9M -$117.9M -$108.2M -$99.36M -$94.78M
Total Stockholders' Equity $31.01M $38.17M $52.20M $60.47M $73.17M $82.54M $90.98M $95.27M
Total Equity $31.01M $38.17M $52.20M $60.47M $73.17M $82.54M $90.98M $95.27M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$36.12M -$26.73M -$23.96M -$14.84M -$10.46M $6.64M
Depreciation & Amortization $16K $11K $12K $9.3K $0 --
Stock-Based Compensation $1.33M $842K $1.08M $976K $511K $219K
Change in Payables $1.10M -$946K $1.45M -$788K -$866K $556K
Operating Cash Flow -$26.39M -$14.56M -$21.05M -$13.55M -$8.80M -$1.03M
Capital Expenditure -$34K -$7.3K $0 -$37K $0 --
Free Cash Flow -$26.42M -$14.56M -$21.05M -$13.59M -$8.80M --
Investing Cash Flow -$2.03M -$14.76M $0 -$537K -$250K $0
Common Stock Issued $0 $14.54M $0 -- -- --
Financing Cash Flow -$15K $109.3M $0 -$102K $58.39M $1.15M
Net Change in Cash -$28.43M $79.98M -$21.05M -$14.19M $49.34M $114K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$7.62M -$14.56M -$8.68M -$13.03M -$9.69M -$8.83M -$4.58M -$3.34M
Depreciation & Amortization $7.5K $6.6K $4.7K $4.1K $4.1K $4.1K $4.1K $2.9K
Stock-Based Compensation $457K $528K $409K $325K $323K $389K $294K $232K
Change in Payables -$1.69M $822K -$67K -$188K $325K $1.39M -$436K $408K
Operating Cash Flow -$6.58M -$7.02M -$11.43M -$8.94M -$6.58M -$5.84M -$5.03M -$4.91M
Capital Expenditure $0 -$18K -$37K $0 $0 $0 -$34K $0
Free Cash Flow -$6.58M -$7.04M -$11.47M -$8.94M -$6.58M -$5.84M -$5.06M -$4.91M
Investing Cash Flow -$2.00M -$4.52M -$37K -$2.00M $0 $0 -$34K $0
Common Stock Issued $0 $0 $0 $15K $0 $0 -$15K --
Financing Cash Flow $0 $0 $0 $0 $0 $0 -$15K $14.54M
Net Change in Cash -$8.58M -$11.54M -$11.47M -$10.94M -$6.58M -$5.84M -$5.08M $9.63M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Return on Equity (ROE) -59.7% -28.1% -201.9% -42.7% -21.7% --
Return on Assets (ROA) -52.7% -27.2% -149.2% -39.1% -20.4% 1421.8%
Current Ratio 8.52x 35.62x 3.83x 11.80x 16.90x 0.03x
Quick Ratio 8.23x 34.36x 3.45x 11.07x 16.36x 0.03x
Debt to Equity 0.00x 0.00x -- 0.00x -- --
Net Income Growth (YoY) -- -- -- -- -257.4% --
EPS Growth (YoY) -- -- -- -- -220.2% --
5Y Net Income / Share Growth -102.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Return on Equity (ROE) -141.6% -120.4% -77.1% -59.7% -36.1% -41.4% -30.4% -28.1%
Return on Assets (ROA) -120.1% -99.6% -68.3% -52.7% -33.4% -39.3% -29.7% -27.2%
Current Ratio 6.59x 5.81x 8.96x 8.52x 13.10x 19.09x 48.80x 35.62x
Quick Ratio 6.26x 5.45x 8.34x 8.23x 12.75x 18.33x 47.02x 34.36x
Debt to Equity 0.01x 0.01x 0.01x 0.00x 0.00x 0.00x 0.00x 0.00x
Source: SEC EDGAR CompanyFacts (CIK 0001842952) · from March 31, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:04 UTC · Open in terminal